|
Houston-Based Firm Makes Deal with Schering-Plough to Develop Asthma Drug.
Publication: Houston Chronicle (Houston, Texas) (via Knight-Ridder/Tribune Business News) Publication Date: 11-JUL-00 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2000 Houston Chronicle
Byline: Mary Sit-DuVall
Jul. 11--Texas Biotechnology, a Houston company that develops drugs for vascular diseases, said Monday it has signed a multimillion-dollar research collaboration and license agreement with Schering-Plough to develop a treatment for asthma.
The pharmaceutical company said it will work with Schering-Plough to develop VLA-4 antagonists, a new class of compounds that has shown promise to treat asthma in animals.
VLA-4 is a naturally occurring protein that is involved in the inflammation of lung tissue....
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Houston Chronicle (Houston, Texas) (via Knight-Ridder/Tribune Business News) |
Houston Chronicle Jim Barlow Column.
July 11, 2000
|
Houston-Based Funeral Services Company Sells Two Foreign Operations.
July 11, 2000
|
Developer Plans to Convert Historic Houston Building into Ritz-Carlton...
July 11, 2000
|
Clinton Orders Heating Oil Reserve of 2 Million Barrels.
July 11, 2000
|
SBC Communications to Offer Compaq Personal Computers to DSL Subscribe...
July 11, 2000
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
